Aurora Cannabis (TSE:ACB) Lifted to Hold at Canaccord Genuity Group

Canaccord Genuity Group upgraded shares of Aurora Cannabis (TSE:ACBGet Rating) from a sell rating to a hold rating in a research report report published on Wednesday morning, BayStreet.CA reports. The firm currently has C$2.00 target price on the stock, down from their previous target price of C$2.50.

Other equities analysts also recently issued research reports about the company. Piper Sandler lowered their price target on Aurora Cannabis to C$4.00 and set a neutral rating on the stock in a research report on Wednesday. Stifel Nicolaus upgraded Aurora Cannabis from a sell rating to a hold rating and lowered their price target for the stock from C$2.50 to C$2.15 in a research report on Monday, June 6th. Cowen increased their price target on Aurora Cannabis from C$1.85 to C$2.00 in a research report on Tuesday, July 19th. Cowen increased their price target on Aurora Cannabis from C$1.85 to C$2.00 in a research report on Tuesday, July 19th. Finally, CIBC decreased their target price on Aurora Cannabis from C$3.75 to C$2.50 in a research report on Monday. One investment analyst has rated the stock with a sell rating and eight have assigned a hold rating to the company’s stock. Based on data from MarketBeat, Aurora Cannabis has an average rating of Hold and a consensus target price of C$3.57.

Aurora Cannabis Stock Performance

Shares of ACB stock opened at C$1.74 on Wednesday. The company has a market capitalization of C$518.08 million and a P/E ratio of -0.29. The business’s 50 day moving average is C$1.98 and its two-hundred day moving average is C$2.86. The company has a current ratio of 5.85, a quick ratio of 3.95 and a debt-to-equity ratio of 35.61. Aurora Cannabis has a 12-month low of C$1.56 and a 12-month high of C$10.87.

Aurora Cannabis Company Profile

(Get Rating)

Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.

Further Reading

Analyst Recommendations for Aurora Cannabis (TSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.